Methods development for assessment of infection rates after human tissue allograft implantation

Ended Awarded Last action

Contract number
HHSF22301005T
Awardee
Awarding agency
Obligated
$676,813

Award facts

Contract value 100% obligated
$676,812.83 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
NAICS code
541690 Other Scientific and Technical Consulting Services
PSC
C118 Research And Development Facilities
Set-aside
No set-aside
Competition
Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
Pricing
Firm Fixed Price
Place of performance
Wellesley Hills, Wellesley, MA 02481, USA

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Close Out 2 -$73,118
Other Administrative Action 1 · TAS 75 0600 TAS task order under to contract W harvard pilgrim - methods development for assessment of infection rates after human tissue allograft implantation… $0
Original award $749,931

Quick answers

Who was awarded contract HHSF22301005T?

HHSF22301005T was awarded to Harvard Pilgrim Health Care, Inc. by Food and Drug Administration (Department of Health and Human Services) on September 7, 2010.

How much is contract HHSF22301005T worth?

The government has obligated $676,813 on HHSF22301005T.

Is contract HHSF22301005T an order under another contract?

Yes. HHSF22301005T is a delivery order under HHSF223200810026I, an indefinite delivery contract.

Was contract HHSF22301005T competed?

The extent of competition for HHSF22301005T was full and open competition. The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award